JP2023516284A5 - - Google Patents
Info
- Publication number
- JP2023516284A5 JP2023516284A5 JP2022550009A JP2022550009A JP2023516284A5 JP 2023516284 A5 JP2023516284 A5 JP 2023516284A5 JP 2022550009 A JP2022550009 A JP 2022550009A JP 2022550009 A JP2022550009 A JP 2022550009A JP 2023516284 A5 JP2023516284 A5 JP 2023516284A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- gating
- therapeutic agent
- cannabidiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021007184 | 2020-02-19 | ||
| IN202021007184 | 2020-02-19 | ||
| IN202021013770 | 2020-03-29 | ||
| IN202021013770 | 2020-03-29 | ||
| PCT/IN2021/050159 WO2021165992A1 (en) | 2020-02-19 | 2021-02-19 | Compositions and therapeutic uses of cannabidiol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516284A JP2023516284A (ja) | 2023-04-19 |
| JP2023516284A5 true JP2023516284A5 (enExample) | 2024-07-09 |
Family
ID=77391770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550009A Pending JP2023516284A (ja) | 2020-02-19 | 2021-02-19 | カンナビジオールの組成物および治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230123654A1 (enExample) |
| EP (1) | EP4106870A4 (enExample) |
| JP (1) | JP2023516284A (enExample) |
| CN (1) | CN115916336A (enExample) |
| AU (1) | AU2021223191A1 (enExample) |
| CA (1) | CA3171890A1 (enExample) |
| IL (1) | IL295753A (enExample) |
| WO (1) | WO2021165992A1 (enExample) |
| ZA (1) | ZA202210355B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4126913A4 (en) * | 2020-03-29 | 2024-09-18 | Akseera Pharma Corp. | INTERACTION OF SARS-COV-2 PROTEINS WITH MOLECULAR AND CELLULAR MECHANISMS OF HOST CELLS AND FORMULATIONS FOR THE TREATMENT OF COVID-19 |
| US20230128114A1 (en) * | 2020-04-02 | 2023-04-27 | Incannex Healthcare Limited | Methods and compositions for treating or preventing an inflammatory condition |
| WO2022122904A1 (en) * | 2020-12-09 | 2022-06-16 | Chanelle Mccoy Cbd Limited | A delayed-release capsule of cannabidiol |
| AU2022204290A1 (en) * | 2020-12-12 | 2023-07-27 | Akseera Pharma Corp. | Cannabidiol for augmenting vaccine mediated immunity and prophylaxis of covid-19 |
| US20240325312A1 (en) * | 2021-07-15 | 2024-10-03 | Incannex Healthcare Limited | Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule |
| WO2024043242A1 (ja) * | 2022-08-23 | 2024-02-29 | 国立大学法人九州大学 | Ｔｒｐｃ３／６／７チャネル活性化による強心作用を介した心不全治療 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087374B2 (en) * | 2003-06-26 | 2006-08-08 | The Research Foundation Of State University Of New York | Screen for sodium channel modulators |
| AU2014244053B2 (en) * | 2013-03-13 | 2018-08-30 | University Of Cincinnati | Treatment of a diastolic cardiac dysfunction with a TRPV2 receptor agonist |
| ES2882588T3 (es) * | 2015-03-31 | 2021-12-02 | Turtle Bear Holdings Llc | Actividad antiviral de setas medicinales y sus constituyentes activos |
| LT6486B (lt) * | 2016-04-13 | 2018-01-10 | UAB "SatiMed" | Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui |
| KR102537990B1 (ko) * | 2016-05-02 | 2023-05-30 | 스테로 바이오텍스 엘티디. | 스테로이드 용량의 감소 및 염증과 자가면역 질환의 치료를 위한 칸나비디올 |
| CN108079305A (zh) * | 2016-11-23 | 2018-05-29 | 汉义生物科技（北京）有限公司 | 大麻二酚与三环类抗抑郁药的药物组合物及其用途 |
| US20180360757A1 (en) * | 2017-05-26 | 2018-12-20 | Altum Pharmaceuticals Inc. | Biphasix cannabinoid delivery |
| WO2019113685A1 (en) * | 2017-12-12 | 2019-06-20 | Cardiol Therapeutics Inc. | Amphiphilic block copolymers, micelles, and methods for treating or preventing heart failure |
| KR102632946B1 (ko) * | 2018-01-13 | 2024-02-05 | 트루티바 인코포레이티드 | 노화 방지 및 피부 톤 미백 조성물 및 이를 위한 방법 |
| CN110575448A (zh) * | 2018-06-08 | 2019-12-17 | 云南汉素生物科技有限公司 | 大麻二酚组合物及其用途 |
| WO2020183456A1 (en) * | 2019-03-10 | 2020-09-17 | Bol Pharma Ltd. | Cannabinoid combinations for treating chronic pain in dialysis patients |
-
2021
- 2021-02-19 CN CN202180029644.1A patent/CN115916336A/zh active Pending
- 2021-02-19 EP EP21756726.2A patent/EP4106870A4/en not_active Withdrawn
- 2021-02-19 WO PCT/IN2021/050159 patent/WO2021165992A1/en not_active Ceased
- 2021-02-19 IL IL295753A patent/IL295753A/en unknown
- 2021-02-19 US US17/800,563 patent/US20230123654A1/en not_active Abandoned
- 2021-02-19 JP JP2022550009A patent/JP2023516284A/ja active Pending
- 2021-02-19 AU AU2021223191A patent/AU2021223191A1/en active Pending
- 2021-02-19 CA CA3171890A patent/CA3171890A1/en active Pending
-
2022
- 2022-09-19 ZA ZA2022/10355A patent/ZA202210355B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516284A5 (enExample) | ||
| Eichhorn et al. | Digoxin | |
| Capucci et al. | Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm:: A prospective parallel placebo-controlled multicentre study | |
| Buckley et al. | Diltiazem: a reappraisal of its pharmacological properties and therapeutic use | |
| Peuhkurinen et al. | Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation | |
| Brubaker et al. | Alternative treatment options for atrioventricular-nodal-reentry tachycardia: an emergency medicine review | |
| Rossoni et al. | The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat | |
| US20110230552A1 (en) | Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack | |
| Park et al. | Antithrombotic therapy for secondary prevention in patients with diabetes mellitus and coronary artery disease | |
| Willens et al. | Cardiovascular manifestations of cocaine abuse: a case of recurrent dilated cardiomyopathy | |
| Thadani et al. | Nitrate therapy for myocardial ischemic syndromes: current perspectives including tolerance | |
| JP3616116B2 (ja) | 心臓血管障害の処置のためのａｃｅ阻害剤を配合するｌ−カルニチンまたはアシル−ｌ−カルニチンを含む医薬組成物 | |
| Rossoni et al. | Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats | |
| Geller et al. | Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation | |
| Zaidel | Amiodarone: updated review of its current usefulness | |
| Aronow et al. | Angina in the elderly | |
| Shiga et al. | Clinical outcome in patients with paroxysmal or persistent atrial fibrillation receiving bepridil | |
| Chukwunyere et al. | COVID-19-related arrhythmias and the possible effects of ranolazine | |
| Hiremath et al. | Pharmaceutical aspects of nicorandil | |
| Cardoso et al. | Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients | |
| Aronow | Drug treatment of elderly patients with acute myocardial infarction: practical recommendations | |
| Kostis et al. | Acute myocardial infarction caused by multivessel coronary spasm due to calcium channel blocker withdrawal | |
| Aleem et al. | Effect of Chloroquine and Hydroxychloroquine on the QT Interval in Patients with COVID-19: A Systematic Review | |
| Dumoulin et al. | Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: relationship to plasma concentrations—a French multicenter trial | |
| Busse et al. | Disposition and pharmacologic effects of R/S‐verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing |